Beijing Scitop Bio-tech Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 264.1 million compared to CNY 268.3 million a year ago. Revenue was CNY 264.1 million compared to CNY 268.3 million a year ago.

Net income was CNY 86.66 million compared to CNY 84.83 million a year ago. Basic earnings per share from continuing operations was CNY 0.3867 compared to CNY 0.38 a year ago. Diluted earnings per share from continuing operations was CNY 0.3867 compared to CNY 0.38 a year ago.